CNF-316 series

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCNF-316 series
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 modulatorsAndrogen Receptor degraders
TargetsAndrogen ReceptorHeat shock protein HSP90
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesConforma Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConforma Therapeutics Corp
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A